The Efficacy and Safety of 'Inverted Omega En-bloc' Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Size-Independent Technique for the Surgical Treatment of LUTSopen accessThe Efficacy and Safety of ‘Inverted Omega En-bloc ’ Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Size-Independent Technique for the Surgical Treatment of LUTS
- Other Titles
- The Efficacy and Safety of ‘Inverted Omega En-bloc ’ Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Size-Independent Technique for the Surgical Treatment of LUTS
- Authors
- Kim, Dae Hyun; Kang, Chang Suk; Choi, Jae Whi; Jeh, Seong Uk; Choi, See Min; Lee, Chun Woo; Kam, Sung Chul; Hwa, Jeong Seok; Hyun, Jae Seog
- Issue Date
- Oct-2023
- Publisher
- MRE PRESS
- Keywords
- Benign prostate hyperplasia; En-bloc; Holmium laser enucleation of the prostate; Lower urinary tract symptoms
- Citation
- JOURNAL OF MENS HEALTH, v.41, no.4, pp 951 - 959
- Pages
- 9
- Indexed
- SCIE
SSCI
SCOPUS
- Journal Title
- JOURNAL OF MENS HEALTH
- Volume
- 41
- Number
- 4
- Start Page
- 951
- End Page
- 959
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/59490
- DOI
- 10.5534/wjmh.220225
- ISSN
- 1875-6867
1875-6859
- Abstract
- Purpose: To evaluate the safety, efficiency, and size-dependency of the 'Inverted omega En-bloc ((sic))' holmium laser enucleation of the prostate (HoLEP) in benign prostate hyperplasia (BPH) with lower urinary tract symptoms. Materials and Methods: A retrospective analysis of 716 consecutive patients who underwent HoLEP under the care of a single surgeon from 2014-2021. These patients were treated using the 'Inverted omega En-bloc' HoLEP technique for BPH. The patients were divided into 3 groups: Group 1 (<40 mL, n=328), Group 2 (40-60 mL, n=221), and Group 3 (<= 60 mL, n=167). Perioperative parameters, safety, and functional outcomes were assessed and analyzed. Results: The perioperative parameters, like enucleation time (45.8 +/- 26.9 min), morcellation time (13.2 +/- 47.5 min), and catheterization duration (1.6 +/- 1.2 d) significantly differed to favor smaller prostate sizes (p<0.01). Significant improvements in the IPSS (total, voiding, storage, and quality of life), post-void residual urine, and maximum flow rate were observed 3 months postHoLEP and continued during the 1-year follow-up period in all groups (p<0.01). The postoperative complications included urethral stricture in 11 patients (1.5%), bladder neck contracture in 12 (1.7%), urinary incontinence in 14 (2.0%), and bladder injuries in 4 (0.6%). Bladder neck contractures occurred only in Group 1. The postoperative surgical management for complications included urethral sounding (n=9, 1.3%), endoscopic internal urethrotomy (n=2, 0.3%), and re-HoLEP for bladder neck contractures in (n=12, 1.7%). The rate of re-HoLEP for regrowing adenomas was 15 (2.1%). Postoperative medications exceeding 6 months were alpha-blocker (n=22, 3.1%), cholinergics (n=16, 2.2%), anticholinergics (n=58, 8.1%), antidiuretics (n=18, 2.5%), and daily PDE5 inhibitor (n=38, 5.3%). Thirty-four patients (4.7%) had postoperative incidental prostate cancer. Conclusions: The inverted omega En-bloc HoLEP technique is safe and effective for the treatment of BPH. Moreover, 'Inverted omega En-bloc' HoLEP is a size-independent and effective method for all prostate sizes.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
- 의학계열 > 의학과 > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.